Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Progenics Pharmaceuticals Inc (NASDAQ:PGNX)

During the Trading Day
5.56 -0.08 / -1.42%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
5.56 0.00 / 0.00%
Volume: 36.1K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Quarter 3
Quarter 4
Quarter 1
Quarter 2
Revenue and IncomeNet Revenues41.7M-571.0K248.0K1.9M
Cost of Goods Sold329.0K27.0K--178.0K
Depreciation And Amortization142.0K126.0K132.0K129.0K
Operating ExpensesGross Income41.2M-724.0K--1.6M
General Expenses10.6M10.0M10.1M12.5M
Research And Development6.7M6.2M6.5M6.5M
Total Operating Expenses11.1M10.2M10.2M12.8M
Non-Operating ExpensesOperating Income30.6M-10.8M-10.0M-10.9M
Extraordinary Credit7.3M--0.000.00
Extraordinary Charge-1.1M-2.2M-300.0K-800.0K
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income36.7M-12.9M-10.3M-11.7M
Income Taxes-227.0K-761.0K0.000.00
Net Income37.0M-12.2M-10.3M-11.7M
Shares To Calculate EPSShares To Calculate EPS69.6M69.6M69.6M69.6M
Shares To Calculate EPS Diluted72.9M69.6M69.6M69.6M
Earnings Per ShareEPS$0.51-$0.18-$0.15-$0.17
EPS Diluted$0.51-$0.18-$0.15-$0.17